Activity value 72united states Buyer&Supplier,Last transaction date:
2026-02-24
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for exemplify biopharma inc. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 4 transactions, with a transaction quantity of 7 and a transaction weight of 0.
YearTransactionsQuantityWeight
202544.750
2026470
Bill of lading data
<
1/15
>
Trade date
2026/02/24
B/L No.
1642340
Suppliers
a1 biochem research (india) private limited
Buyers
exemplify biopharma inc.
POLs
hyderabad
PODs
trenton
Supply area
India
Purchas area
United States
Weight
——
Amount
1474886
Hs code
29339990
Product tags
riva,pyridine
Product description
OD 0176715 PYRIDINE DERIVATIVE
Expand
Trade date
2026/02/13
B/L No.
5224201
Suppliers
a1 biochem research (india) private limited
Buyers
exemplify biopharma inc.
POLs
hyderabad
PODs
trenton
Supply area
India
Purchas area
United States
Weight
——
Amount
1151195.5
Hs code
29339990
Product tags
riva,pyridine
Product description
OD 0176715 PYRIDINE DERIVATIVE
Expand
Trade date
2026/02/05
B/L No.
0300128
Suppliers
a1 biochem research (india) private limited
Buyers
exemplify biopharma inc.
POLs
hyderabad
PODs
john f. kennedy apt/new york
Supply area
India
Purchas area
United States
Weight
——
Amount
4475000
Hs code
29339990
Product tags
oxalate
Product description
OD 0176072 OXALATE
Expand
Trade date
2026/02/05
B/L No.
6654663
Suppliers
a1 biochem research (india) private limited
Buyers
exemplify biopharma inc.
POLs
hyderabad
PODs
john f. kennedy apt/new york
Supply area
India
Purchas area
United States
Weight
——
Amount
4654000
Hs code
29329990
Product tags
riva,pyran
Product description
OD 0176071 PYRANONE DERIVATIVE
Expand
Trade date
2025/12/17
B/L No.
6844862
Suppliers
a1 biochem research (india) private limited
Buyers
exemplify biopharma inc.
POLs
hyderabad
PODs
newark
Supply area
India
Purchas area
United States
Weight
——
Amount
2688000
Hs code
29329990
Product tags
riva,pyran
Product description
OD 0176071 PYRANONE DERIVATIVE
Expand
Trade date
2025/12/17
B/L No.
5354037
Suppliers
a1 biochem research (india) private limited
Buyers
exemplify biopharma inc.
POLs
hyderabad
PODs
newark
Supply area
India
Purchas area
United States
Weight
——
Amount
2688000
Hs code
29329990
Product tags
riva,pyran
Product description
OD 0176071 PYRANONE DERIVATIVE
Expand
Trade date
2025/04/04
B/L No.
0797407
Suppliers
firmus laboratories pvt ltd.
Buyers
exemplify biopharma inc.
exemplify biopharma inc. is united states Buyer&Supplier,
and primarily engages in the import and export business of products such as tablet,tooling,ppe.
According to the 52wmb.com global trade database, as of 2026-02-24, the company has completed 79 international trades,
with its main trading regions covering india,costa rica etc.
The core products include HS84799040,HS82073000,HS84798970 etc,
often transported via newark apt/new york,port new york, port newark nj etc,
and its main trading partners are ktt pharmatech,syngene international ltd.,a1 biochem research (india) private limited.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on exemplify biopharma inc. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.